Tokyo, Oct. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063119) titled 'A study of the efficacy and side effects of nelandmilast treatment in patients with interstitial lung disease' on Sept. 30.
Study Type:
Observational
Primary Sponsor:
Institute - Kyoto Prefectural University of Medicine
Condition:
Condition - idiopathic pulmonary fibrosis, progressive pulmonary fibrosis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to prospectively evaluate the real-world efficacy and safety of nerandomilast in patients with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). Additionally, this study exami...